AwardsIdentified for RadioGraphics
ParticipantsDiego N. dos Santos, MD, Sao Paulo, Brazil (Presenter) Nothing to Disclose
Marcelo Mota, Sao Paulo, Brazil (Abstract Co-Author) Nothing to Disclose
George A. Veloso Filho, DDS, Sao Paulo, Brazil (Abstract Co-Author) Nothing to Disclose
Karla Schoen, MD, Sao Paulo, Brazil (Abstract Co-Author) Nothing to Disclose
Adriano Basso Dias, MD, Toronto, Ontario (Abstract Co-Author) Nothing to Disclose
Natally Horvat, MD, Sao Paulo, Brazil (Abstract Co-Author) Nothing to Disclose
Publio C. Viana, MD, Sao Paulo, Brazil (Abstract Co-Author) Nothing to Disclose
diegodns@gmail.com
TEACHING POINTS• Review the prostate anatomy and its imaging features • Summarize the strengths and limitations of prostate cancer imaging modalities • Describe the role of the different methods in diverse clinical contexts (screening, detection, staging, active surveillance and biochemical recurrence) • Highlight the role of the novel imaging modalities on prostate cancer
TABLE OF CONTENTS/OUTLINEIntroduction - Prostate cancer epidemiology and clinical features - Anatomical landmarks and histological concepts Traditional imaging modalities on prostate cancer - Transrectal ultrasound - CT - mpMRI - 68Ga PSMA PET-CT Role of the different methods in diverse clinical contexts - Screening - Detection - Staging - Active surveillance - Biochemical recurrence Novel modalities on prostate cancer - 68Ga-PSMA PET/MRI Local detection and primary staging T Staging N Staging M Staging Biochemical Recurrence Assessment of therapeutic response - Micro-ultrasound Promising role on prostate cancer Detection and biopsy guidance (one-stop-shop approach) Active surveillance Assessment after focal therapies Prostate Risk Identification Using Micro-Ultrasound (PRI-MUS) score